Melatonina Alter

Melatonin, the active ingredient in Melatonina Alter, is a melatonin receptor agonist presented as an oral formulation for oral use. It treats insomnia, jet lag and sleep‑wake rhythm disorders in adults and children as appropriate.

GNH USA supplies Melatonina Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin MT1 and MT2 receptors to regulate circadian rhythm and support sleep. - Insomnia: helps initiate and maintain sleep, reducing sleep latency. - Jet lag: assists in adjusting the internal clock after rapid time‑zone travel. - Sleep‑wake rhythm disorders: stabilises disrupted sleep patterns in shift‑work or delayed‑sleep‑phase conditions.

Melatonin is generally well tolerated, but some users experience adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness. - Nausea: mild stomach upset. - Vivid dreams: unusually intense or memorable dreams.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety. - Hormonal effects: menstrual irregularities in women. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm in susceptible individuals.

When considering melatonin therapy, certain safety measures are recommended. - Pregnancy: consult a healthcare professional before use; safety data are limited. - Breastfeeding: discuss potential exposure with a physician. - Pediatric use: dosing and duration should be determined by a pediatric specialist. - Drug interactions: review concomitant medications for possible interactions. - Underlying conditions: assess for depression, epilepsy, or autoimmune disorders before initiating therapy. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Melatonin may influence the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: could reduce efficacy of immune‑modulating therapy.

Moderate Interactions (Monitor Closely): - Sedatives or CNS depressants: may enhance drowsiness. - Oral contraceptives: potential reduction in hormonal effectiveness. - Antidiabetic agents: possible alteration of blood glucose control. - Antidepressants (SSRIs, MAOIs): may affect serotonin pathways. - Antihypertensives: could cause additive blood‑pressure lowering effects.